Shares of Kirkland's, Inc. (NASDAQ: KIRK) gained more than 3 percent in pre-market trading after the company reported stronger-than-expected earnings for the fiscal first quarter on Thursday.
The Brentwood, Tennessee-based company posted...
Analysts at EVA Dimensions upgraded Kirkland's Inc. (NASDAQ: KIRK) from Sell to Overweight.
Kirkland's shares have gained 23.92% over the past 52 weeks, while the S&P 500 index has surged 10.69% in the same period.
Kirkland's shares dropped...
Kirkland's Inc. (NASDAQ: KIRK) reported in-line earnings for the fiscal fourth quarter on Thursday.
The Brentwood, Tennessee-based company posted a quarterly profit of $15.6 million, or $0.87 per share, up from $12.3 million, or $0.69 per share,...
In a report published Tuesday, Barrington Research analyst Kristine Koerber reiterated an Outperform rating on Kirkland's, Inc. (NASDAQ: KIRK), and raised the price target from $24.00 to $28.00.
In the report, Barrington Research noted, “We...
In trading on Thursday, home furnishings & improvement shares were relative leaders, up on the day by about 3.5%. Leading the group were shares of Kirklands (KIRK), up about 16.6% and shares of Williams Sonoma (WSM) up about 9.6% on the day.
By SA Transcripts:
Kirkland's, Inc. (NASDAQ:KIRK)
Q2 2014 Results Earnings Conference Call
August 21, 2014, 11:00 AM ET
Tripp Sullivan - SCR Partners
Robert Alderson - CEO
Mike Madden - President and COO
Adam Holland -...
Kindred Biosciences (NASDAQ: KIN) shares dipped 28.36% to $10.18 after the company reported that its pivotal field study (KB010) of CereKin did not meet its primary endpoint.
Ampio Pharmaceuticals (NYSE: AMPE) shares fell 19.84% to $5.98 after...
Oops! Unable to complete your request. Please refresh your browser.